Situaciones de broncoespasmo, obstrucción de las vías aéreas superiores, hipersecreción bronquial y determinadas características de los circuitos externos del. Contraindicada en casos de hipersensibilidad a la levodropropizina o compuestos estructuralmente relacionados, hipersecreción bronquial o función. Se asocia a: Hiperreactividad bronquial con episodios recurrentes de sibilancias, disnea, opresión torácica y tos. Obstrucción bronquial difusa.
|Published (Last):||17 September 2016|
|PDF File Size:||14.75 Mb|
|ePub File Size:||1.15 Mb|
|Price:||Free* [*Free Regsitration Required]|
Short term response of patients with bronchiectasis to treatment with amoxycillin given in standard or high doses orally or by inhalation. Clinical interpretation of airway response to a bronchodilator: Global Strategy for Asthma Management and Prevention.
Aerosolized vancomycin for the treatment hipersecrrecion methicillin-resistant staphylococcus aureus infection in cystic fibrosis. Suggestions for prevention and infection control.
Randomized, controlled, double blind, parallel, prospective design with rescue medication. Long-term treatment benefits with tiotropium in COPD patients with and without short-term bronchodilator responses. A pilot study of low-dose erythromycin in bronchiectasis. Long-term azithromycin for Indigenous children with non-cystic-fibrosis bronchiectasis or chronic suppurative lung disease Bronchiectasis Intervention Study: Measurement of reversibility of airways obstruction: Time course of action of two inhaled corticosteroids, fluticasone propionate and budesonide.
Criteria for the assessment of reversibility in airways obstruction. Treatment of idiopathic bronchiectasis with aerosolized recombinant human DNase I.
Inhaled steroids in patients with bronchiectasis.
Bronchodilator reversibility testing in chronic obstructive pulmonary disease. Effect of long-term, low-dose erythromycin on pulmonary exacerbations among patients with non-cystic fibrosis bronchiectasis: Long-term mortality among adults with asthma: Short- and long-term antibiotic treatment reduces airway and systemic inflammation in non-cystic hippersecrecion bronchiectasis. At the end of treatment a reduced progression and severity of oxidative stress in the acebrofilin group was observed.
Monografías de Archivos de Bronconeumología
This abstract may be abridged. Efficacy of nebulised colomycin in patients with non-cystic fibrosis bronchiectasis colonised with Pseudomonas aeruginosa. Interpretative strategies for lung function tests.
Brain B, et al. Repeatibility of spirometry in 18, adult patients. Chronic bronchopulmonary diseases involving inflammation, bronqulal and bronchial hyperreactivity, such as asthma, chronic bronchitis and chronic obstructive pulmonary disease COPD are common causes of medical consultation.
J Hipersecredion Clin Immunol. Long-term treatment of bronchiectasis and chronic bronchitis; a controlled study of the effects of tetracycline, penicillin, and an oleandomycin-penicillin mixture. Official Statement of the European Respiratory Society.
An evaluation of test used to measure bronchodilator response. Unorthodox long-term aerosolized ampicillin use for methicillin-susceptible Staphylococcus aureus lung infection in a cystic fibrosis patient. Safety and tolerability of medication were also evaluated. TS, Chalmers JD, et al.
Tratamiento de las bronquiectasias | Girón Moreno | Monografías de Archivos de Bronconeumología
Ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis: There was no difference in tolerability between the two groups. Association between fraction of exhaled nitrous oxide, bronchodilator response and inhaled corticosteroid type. A single measure of FEV1 is associated with risk of asthma attacks in long-term follow-up. Inhaled colistin in patients with bronchiectasis and chronic Pseudomonas aeruginosa infection.
Effect of long-term nebulized colistin on lung function and quality of life in patients with chronic bronchial sepsis. Phase 3 randomized study of the efficacy and safety of inhaled dry powder mannitol for the symptomatic treatment of non-cystic fibrosis bronchiectasis. Double-blind randomized multicenter study versus placebo. Eur J Respir Dis Suppl. Pisi G, Chetta A. Kesten S, Rebuck AS. Hematology, blood chemical values and urinalysis.
Use of nebulised saline and nebulised terbutaline as an adjunct to chest physiotherapy.
Phase 3 efficacy bornquial safety data from randomized, multicentre study of liposomal amikacin for inhalation Arikace compared with Tobi R in cystic fibrosis patients with chronic infection due to Pseudomonas aeruginosa.
FEV1 response to bronchodilation in an adult urban population.